UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management and Prevention of Cellular-Therapy-Related Toxicity: Early and Late Complications

Current oncology (Toronto), 2023-05, Vol.30 (5), p.5003-5023

2023

Volltextzugriff (PDF)

Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies

Frontiers in immunology, 2020-07, Vol.11, p.1625-1625

2020

Volltextzugriff (PDF)

Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study)

Clinical cardiology (Mahwah, N.J.), 2020-10, Vol.43 (10), p.1055-1063

2020

Volltextzugriff (PDF)

Critically ill patients with severe immune checkpoint inhibitor related neurotoxicity: A multi-center case series

Journal of critical care, 2021-10, Vol.65, p.126-132

2021

Volltextzugriff (PDF)

Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS‐CoV‐2

American journal of transplantation, 2020-11, Vol.20 (11), p.3191-3197

2020

Volltextzugriff (PDF)

Risk factors associated with development of coinfection in critically Ill patients with COVID-19

Acute and Critical Care, 2022, 37(3), , pp.312-321

2022

Volltextzugriff (PDF)

A High Neutrophil-Lymphocyte Ratio Is Associated With Increased Morbidity and Mortality in Patients With Coronavirus Disease 2019

Critical care explorations, 2021-05, Vol.3 (5), p.e0444-e0444

2021

Volltextzugriff (PDF)

Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis

Critical care explorations, 2021-01, Vol.3 (1), p.e0327-e0327

2021

Volltextzugriff (PDF)

A Contemporary Analysis of Ethics Consultations in an Oncologic ICU

Chest, 2012-10, Vol.142 (4), p.759A-759A

2012

Volltextzugriff (PDF)

Pulmonary Arterial Hypertension After Hematopoeitic Stem Cell Transplant

Chest, 2012-10, Vol.142 (4), p.118A-118C

2012

Volltextzugriff (PDF)

1113: COVID REDUX: THE RISK TO CRITICALLY ILL CANCER PATIENTS REMAINS HIGH

Critical care medicine, 2023-01, Vol.51 (1), p.554-554

2023

Volltextzugriff (PDF)

Toxicities Associated with Immunotherapy and Approach to Cardiotoxicity with Novel Cancer Therapies

Critical care clinics, 2021-01, Vol.37 (1), p.47-67

2021

Volltextzugriff (PDF)

702: Immune Checkpoint Inhibitor-Associated Neurotoxicity Prompting Intensive Care Unit Admission

Critical care medicine, 2021-01, Vol.49 (1), p.346-346

2021

Volltextzugriff (PDF)

Addressing caregiver moral distress during the COVID-19 pandemic

Cleveland Clinic journal of medicine, 2020-06

2020

Volltextzugriff (PDF)

Ethical considerations during the COVID-19 pandemic

Cleveland Clinic journal of medicine, 2020-06

2020

Volltextzugriff (PDF)

Surge capacity and capability of intensive care units across a large healthcare system: An operational blueprint for regional integration

American journal of disaster medicine, 2021, Vol.16 (3), p.179-192

2021

Volltextzugriff (PDF)

Practical aspects of targeting IL-6 in COVID-19 disease

Cleveland Clinic journal of medicine, 2020-10

2020

Volltextzugriff (PDF)

Critically ill patients with severe immune checkpoint inhibitor related neurotoxicity: A multicenter case series

Journal of critical care, 2021-06, Vol.65, p.126-132

2021

Volltextzugriff (PDF)

Indicators of Clinical Trajectory in Patients With Cancer Who Receive Cardiopulmonary Resuscitation

Journal of the National Comprehensive Cancer Network, 2023-01, Vol.21 (1), p.51-59.e10

2023

Volltextzugriff (PDF)

Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study

Critical care medicine, 2022-01, Vol.50 (1), p.81-92

2022

Volltextzugriff (PDF)

482: Chimeric Antigen Receptor (CAR) Cell Patients Admitted to the ICU: The CAR-ICU Initiative Experience

Critical care medicine, 2021-01, Vol.49 (1), p.232-232

2021

Volltextzugriff (PDF)

460: Neurotoxicity in Critically Ill Chimeric Antigen Receptor (CAR) Patients: The CAR-ICU Experience

Critical care medicine, 2021-01, Vol.49 (1), p.221-221

2021

Volltextzugriff (PDF)

44: Cytokine Release Syndrome in Chimeric Antigen Receptor T-Cell Therapy: The CAR-ICU Experience

Critical care medicine, 2021-01, Vol.49 (1), p.23-23

2021

Volltextzugriff (PDF)

Prescribing Patterns for Corticosteroids in Septic Shock: Translating Guidelines to Bedside Practice

Critical care medicine, 2013-10, Vol.41 (10), p.2441-2443

2013

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Humans
(10)
Critical Care Medicine
(8)
General & Internal Medicine
(8)
Covid-19
(6)
Cytokine Release Syndrome
(5)
Female
(5)
Intensive Care Unit
(5)
Male
(5)
Middle Aged
(5)
Oncology
(4)
Sars-Cov-2
(4)
Aged
(3)
Antibodies, Monoclonal, Humanized - Therapeutic Use
(3)
Comorbidity
(3)
Hospitals
(3)
Inflammation
(3)
Monoclonal Antibodies
(3)
Neoplasms - Therapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management and Prevention of Cellular-Therapy-Related Toxicity: Early and Late Complications

Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies

Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study)

Critically ill patients with severe immune checkpoint inhibitor related neurotoxicity: A multi-center case series

Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS‐CoV‐2

The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities

Risk factors associated with development of coinfection in critically Ill patients with COVID-19

A High Neutrophil-Lymphocyte Ratio Is Associated With Increased Morbidity and Mortality in Patients With Coronavirus Disease 2019

Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis

A Contemporary Analysis of Ethics Consultations in an Oncologic ICU

Pulmonary Arterial Hypertension After Hematopoeitic Stem Cell Transplant

1113: COVID REDUX: THE RISK TO CRITICALLY ILL CANCER PATIENTS REMAINS HIGH

Toxicities Associated with Immunotherapy and Approach to Cardiotoxicity with Novel Cancer Therapies

702: Immune Checkpoint Inhibitor-Associated Neurotoxicity Prompting Intensive Care Unit Admission

Addressing caregiver moral distress during the COVID-19 pandemic

Ethical considerations during the COVID-19 pandemic

Surge capacity and capability of intensive care units across a large healthcare system: An operational blueprint for regional integration

Practical aspects of targeting IL-6 in COVID-19 disease

Critically ill patients with severe immune checkpoint inhibitor related neurotoxicity: A multicenter case series

Indicators of Clinical Trajectory in Patients With Cancer Who Receive Cardiopulmonary Resuscitation

Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study

482: Chimeric Antigen Receptor (CAR) Cell Patients Admitted to the ICU: The CAR-ICU Initiative Experience

460: Neurotoxicity in Critically Ill Chimeric Antigen Receptor (CAR) Patients: The CAR-ICU Experience

44: Cytokine Release Syndrome in Chimeric Antigen Receptor T-Cell Therapy: The CAR-ICU Experience

Prescribing Patterns for Corticosteroids in Septic Shock: Translating Guidelines to Bedside Practice

Suchergebnisse filtern